Francis Plat
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Francis Plat
Milestone Pharmaceuticals Inc. reported in an 8-K filed December 6, 2022 that Francis Plat retired as Chief Scientific Officer, effective December 31, 2022. The proxy statement of Milestone Pharmaceuticals Inc. reports total compensation of $1,204,602 for Francis Plat in fiscal 2021, including a base salary of $404,875. Disclosed compensation is on record for 4 fiscal years.
“Mr. Oliveto, the Company's Chief Executive Officer, announced Mr. Francis Plat's intention to retire as Chief Scientific Officer from the Company, effective December 31, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Milestone Pharmaceuticals Inc. (MIST)
Proxy statement
Start not stated–2022-12-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Milestone Pharmaceuticals Inc. (MIST) | Chief Science Officer ^^ | $404,875 | $1,204,602 |
| 2020 | Milestone Pharmaceuticals Inc. (MIST) | Chief Science Officer ^^ | $378,067 | $1,810,191 |
| 2019 | Milestone Pharmaceuticals Inc. (MIST) | Chief Medical Officer | $380,692 | $579,092 |
| 2018 | Milestone Pharmaceuticals Inc. (MIST) | Chief Medical Officer | $330,000 | $636,609 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.